Systematic Analysis of Chemokines Reveals CCL18 is a Prognostic Biomarker in Glioblastoma Article Swipe
Related Concepts
Glioma
Chemokine
CCL18
CXCL5
CXCL1
Biology
CCL7
Cancer research
Chemokine receptor
Immunology
Immune system
Wenqing Gao
,
Yuanyuan Li
,
Teng Zhang
,
Jianglong Lu
,
Jiasong Pan
,
Qi Qi
,
Siqi Dong
,
Xiangjun Chen
,
Zhipeng Su
,
Jixi Li
·
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.2147/jir.s357787
· OA: W4285740125
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.2147/jir.s357787
· OA: W4285740125
Our study reveals comprehensive and comparable roles of chemokine members in glioblastoma, and identified CCL18 as a critical driver of GBM malignant behaviors, therefore providing a potential target for developing prognosis and therapy in human glioblastoma.
Related Topics
Finding more related topics…